Alum (AlK(SO4)2) is an adjuvant commonly utilized in vaccines, and is a ubiquitous element used extensively in contemporary life. Food, air, water, waste, the earth’s surface, and pharmaceuticals all represent pathways of aluminum (Al) exposure. Crohn's disease (CD) is a chronic relapsing intestinal inflammation in genetically susceptible individuals and is caused by yet unidentified environmental factors. Al is a potential factor for the induction of inflammation in CD, and its immune activities share many characteristics with the immune pathology of CD: many luminal bacterial or dietary compounds can be adsorbed to the metal surface and induce Th1 profile cytokines, shared cytokines/chemokines, co-stimulatory molecules, and intracellular pathways and stress-related molecular expression enhancement, affecting intestinal macrobiota, trans-mural granuloma formation, and colitis induction in an animal CD model. The inflammasome plays a central role in Al mode of action and in CD pathophysiology. It is suggested that Al adjuvant activity can fit between the aberrations of innate and adaptive immune responses occurring in CD. The CD mucosa is confronted with numerous inappropriate bacterial components adsorbed on the Al compound surface, constituting a pro-inflammatory supra-adjuvant. Al fits the diagnostic criteria of the newly described autoimmune/inflammatory syndrome induced by adjuvants. If a cause and effect relationship can be established, the consequences will greatly impact public health and CD prevention and management.
SartorRB. Key questions to guide a better understanding of host-commensal microbiota interactions in intestinal inflammation. Mucosal Immunol2011; 4: 127–132.
2.
BamiasGNyceMRDe La RueSACominelliF. New concepts in the pathophysiology of inflammatory bowel disease. Ann Inter Med2005; 143: 895–904.
3.
SartorRB. Therapeutic manipulation of the enteric microflora in inflammatory bowel disease: antibiotics, probiotics, and prebiotics. Gastroenterology2004; 126: 1620–1633.
4.
LernerAShoenfeldY. Serological markers in inflammatory bowel disease: the pros and cons. Eur J Gastroenterol Hepatol2002; 14: 103–105.
5.
MahmudNWeirDG. The urban diet and Crohn's disease: is there a relationship?Eur J Gastroenterol Hepatol2001; 13: 93–95.
6.
XiaTLLiNNelAE. Potential health impact of nanoparticles. Ann Rev Pub Health2009; 30: 137–150.
7.
PowellJJFariaNThomas-McKayEPeleLC. Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun2010; 34: j226–j233.
8.
GanrotPO. Aluminum: possible etiologic agent in Crohn's disease. In: JarnerotG (eds). Inflammatory bowel diseaseNew York: Raven Press; 1987. 119–128.
9.
PerlDPFogartyUHarpazN. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn's disease. Inflamm Bowel Dis2004; 10: 881–883.
10.
LernerA. Extended hypothesis: Aluminum is a potential environmental factor for Crohn's disease induction. Ann N Y Acad Sci2007; 1107: 329–345.
11.
LomerMCThompsonRPPowellJJ. Fine and ultrafine particles of the diet: influence on the mucosal immune response and association with Crohn's disease. Proc Nutr Soc2002; 61: 123–130.
12.
ShepherdNACrockerPRSmithAP. Exogenous pigment in Peyer's patches. Hum Pathol1987; 18: 50–54.
13.
UrbanskiSJArsenaultALGreenFH. Pigment resembling atmospheric dust in Peyer's patches. Mod Pathol1989; 2: 222–226.
14.
PowellJJAinleyCHarveyRS. Characterization of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut2007; 38: 390–395.
15.
PowellJJThoreeVPeleLC. Dietary microparticles and their impact on tolerance and immune responsiveness of the gastrointestinal tract. Br J Nutr2007; 98: s59–s63.
16.
ChessSChessDOlanderG. Production of chronic enteritis and other systemic lesions by ingestion of finely divided foreign materials. Surgery1950; 27: 220–234.
17.
FogartyUPerlDGoodP. A cluster of equine granulomatous enteritis cases: the link with aluminium. Vet Hum Toxicol1998; 40: 297–305.
18.
LernerAEluriSPerlD. Bacterial-aluminum interactions. The role of aluminum in bacterial-induced colitis in IL-10 deficient mice. Gastroenterology2006; 130: 362–363. abstract).
19.
Di SabatinoACiccocioppoRLuinettiO. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum2003; 46: 1498–1507.
20.
LernerA. New therapeutic strategies for celiac disease. Autoimmun Rev2010; 9: 144–147.
21.
SalimSYSoderholmJD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis2011; 17: 362–381.
22.
ZakiMHLamkanfiMKannegantiTD. The Nlrp3 inflammasome: contributions to intestinal homeostasis. Trends Immunol2011; 32: 171–179.
23.
AimaniandaVHaenslerJLacroix-desmazesSKaveriSVBayryJ. Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. Trends Pharmacol Sci2009; 30: 287–295.
24.
MankertzJSchulzkeJD. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol2007; 23: 379–383.
25.
GullbergESoderholmJD. Peyer's patches and M cells as a potential sites of the inflammatory onset in Crohn's disease. Ann N Y Acad Sci2006; 1072: 218–232.
26.
AshwoodPThompsonRPPowellJJ. Fine particles that adsorb lipopolysacchride via bridging calcium cations may mimic bacterial pathogenicity towards cells. Exp Biol Med2007; 232: 107–117.
27.
PowellJJHarveyRSAshwoodPWolstencroftRGershwinMEThompsonRP. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun2000; 14: 99–105.
28.
EvansSMAshwoodPWarleyABerishaFThompsonRPHPowellJJ. The role of dietary microparticles and calcium in apoptosis and interleukin-1ß release of intestinal macrophages. Gastroenterology2002; 123: 1543–1553.
29.
ThoreeVSkepperJDeereHPeleLCThompsonRPPowellJJ. Phenotype of exogenous microparticle-containing pigment cells of the human Peyer's patch in inflamed and normal ileum. Inflamm Res2008; 57: 374–378.
30.
PeleLCPowellJJ. Microparticles: a link between modern life and inflammatory bowel disease? In: ColombelJFGascheCScholmerichJVucelicB (eds). IBD: translation from basic research to clinical practiceDordrecht: Kluwer Academic Publishers; 2005. 123–137.
31.
PowellJJHarveyRSThompsonRP. Microparticles in Crohn's disease–has the dust settled?Gut1996; 39: 340–341.
32.
LomerMCHutchinsonCVolkertS. Dietary sources of inorganic microparticles and their intake in healthy subjects and patients with Crohn's disease. Br J Nutr2004; 92: 947–955.
33.
ButlerMBoyleJJPowellJJPlayfordRJGhoshS. Dietary microparticles implicated in Crohn's disease can impair macrophage phagocytic activity and act as adjuvants in the presence of bacterial stimuli. Inflamm Res2007; 56: 353–361.
34.
MannhalterJWNeychevHOZlabingerGJ. Modulation of the human immune response by the non-toxic and non-pyrogenic adjuvant aluminium hydroxide: effect on antigen uptake and antigen presentation. Clin Exp Immunol1985; 61: 143–151.
35.
SaitohTFujitaNJangMH. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature2008; 456: 264–268.
36.
LomerMCHarveyRSEvansS-M. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur J Gastroenterol Hepatol2001; 13: 101–106.
37.
LomerMCGraingerSL. Lack of efficacy of a reduced microparticle diet in a multi-centred trial of patients with active Crohn's disease. Eur J Gastroenterol Hepatol2005; 17: 377–384.
38.
MitsuhashiMTarganSR. Ex vivo stimulation of IgG Fc and T-cell receptor function: an application to inflammatory bowel disease. Inflamm Bowel Dis2006; 14: 1061–1067.
39.
VuckovicSFlorinTHKhalilD. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel disease. Am J Gastroenterology2001; 96: 2946–2956.
40.
PhilpottJRMinerPBJr. Antisense inhibition of ICAM-1 expression as therapy provides insight into basic inflammatory pathways through early experiences in IBD. Expert Opin Biol Ther2008; 8: 1627–1632.
StallmachAGieseTSchmidtC. Cytokine/chemokine transcript profiles reflect mucosal inflammation in Crohn's disease. Int J Colorectal Dis2004; 19: 308–315.
43.
KaserABlumbergRS. Autophagy, microbial sensing, endoplasmic reticulum stress, and epithelial function in inflammatory bowel disease. Gastroenterology2011; 140: 1738–1747.
44.
MarrackPMcKeeAMunksMW. Towards an understanding of the adjuvant action of aluminum. Nature Rev Immunol2009; 9: 287–293.
45.
DotanIFishmanSDganiY. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn’s disease. Gastroenterology2006; 131: 366–378.
46.
LindbladEB. Aluminum compounds for use in vaccines. Immun Cell Biol2004; 82: 497–505.
47.
WasanSKBakerSESkolnikPRFarrayeFA. A practical guide to vaccinating the inflammatory bowel disease. Patient Amer J Gastroenterol2010; 105: 1231–1238.
48.
Bamonti F, Fulgenzi A, Novembrino C, Ferrero ME. Metal chelation therapy in rheumatoid arthritis: a case report. Biometals 2011; 24: 1093–1098.
49.
Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Macrophage myofasciitis a vaccine (alum) autoimmune-related disease. Clin Rev Allergy Immun 2011; 41: 163–168.
50.
FlatenTP. Aluminum as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res Bull2001; 15: 187–196.
51.
ExleyCMamutseGKorchazhkinaO. Elevated urinary excretion of aluminum and iron in multiple sclerosis. Mult Scler2006; 12: 533–540.
52.
CaiHRCaoMMengFQWeiJY. Pulmonary sarcoid-like granulomatosis induced by aluminum dust: report of a case and literature review. Chin Med J2007; 120: 1556–1560.
53.
de CarvalhoJFPereiraRMShoenfeldY. The mosaic of autoimmunity: the role of environmental factors. Front Biosci (Elite edn)2009; 1: 501–509.
54.
MolinaVShoenfeldY. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity2005; 38: 235–245.
55.
ShoenfeldY. Infections, vaccines and autoimmunity. Lupus2009; 18: 1127–1128.
56.
IsraeliEAgmon-LevinNBlankMShoenfeldY. Adjuvants and autoimmunity. Lupus2009; 18: 1217–1225.
57.
FournieGJMasMCautainB. Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals. J Autoimmun2001; 16: 319–326.
58.
MeroniPL. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truth and a new syndrome?J Autoimmun2011; 36: 1–3.
59.
ShoenfeldYAgmon-levinN. ‘ASIA’-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun2011; 36: 4–8.
